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Abstract 
 
According to the McKnight Brain Institute, at least 10,000 people annually in the USA suffer from 
a central nervous system (CNS) injury. These injuries can cause serve disabilities including 
paralysis. Due to the complexity of the spinal cord, it is common that potential CNS treatments are 
first applied to an optic nerve crush (ONC) model in rats. Two proposed treatments were 
employed; one where nerve growth factor (NGF) was immobilized to a chitosan substrate to 
stimulate axonal regeneration, and the other using pentadecafluorooctanoyl chloride modified 
methacrylamide chitosan (MAC(Ali15)F) hydrogel to enhance local oxygenation. The two 
different treatments were formed into wraps and directly applied to the ONC. The treatments were 
evaluated using behavioral analysis and immunohistochemistry. There was no significant 
difference between the treatment and control groups due to flaws in the material and surgical 
procedures. The crush was only confirmed in 38% of the rats. Also, the NGF released from the 
material was considerably lower than similar published studies. In addition, the MAC(Ali15)F was 
used in such a small amount and was not loaded with oxygen prior to use. Despite the failure of 
this study, the possibilities for future work with biomaterial based CNS injury treatments have 
been highlighted. 
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Executive Summary 
 
According to the McKnight Brain Institute at the University of Florida, at least 10,000 
people per year in the United States alone suffer from a central nervous system (CNS) injury. 
These types of injuries in the worst cases can cause serve disabilities including paralysis. Due to 
the complexity of the spinal cord, it is common that potential CNS treatments are first applied to 
an optic nerve model. The optic nerve is a bundle of continuous axons that extend from the retina 
of the eye to the brain to pass on visual information. Because all of the axons start and stop in the 
same place, it is simpler to trace the axons and analyze their regeneration after injury then in the 
spinal cord. In the optic nerve crush (ONC) model, the optic nerve is exposed and subjected to a 
mild crush and some axons are damaged, without completely severing the optic nerve. This model 
has been used numerous times to study axon regeneration treatments.  
Two proposed treatments for an ONC injury were employed in this study. One where nerve 
growth factor (NGF) was immobilized to a chitosan substrate to stimulate axonal regeneration. 
The other using pentadecafluorooctanoyl chloride modified methacrylamide chitosan 
(MAC(Ali15)F) hydrogel to reduce damage from reactive oxygen species and enhance local 
oxygenation. The two different treatments were formed into tubes or wraps that were directly 
applied to the optic nerve after injury in male Sprague Dawley rats. The treatments were evaluated 
using behavioral analysis and immunohistochemistry (IHC). There was no significant and 
consistent trend in the behavioral analysis. The IHC reviled that there was a significant difference 
between the uninjured optic nerves and the ones that received the ONC injury, but there was no 
difference between the groups that received a treatment and the ones that did not. It was a 
concluded that an injury did occur, but was not consistent or sever enough to test the efficacy of 
the different treatments.  
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The inconclusive results of this study are most likely due to flaws in the material design 
and the surgical procedures. The crush was only visually confirmed on 38% of the rats that 
received the injury, so it was not consistent across all the groups. Also, the nerve growth factor 
released from the material used in this study was orders of magnitude lower than similar published 
studies. In addition, the fluorinated chitosan was used in such a small amount that in order to 
observe an effect, more material would be required. Even though this preliminary study was not 
successful, much was learned about the optic nerve crush model and how these types of treatments 
could be applied. For example, since the immobilized protein by itself was not sufficient, it could 
be coupled with soluble proteins or additional neural growth stimulants to better treat the injury. 
Overall, even though this novel approach to the treatment of an ONC injury was not initially 
successful, none of the results indicated that using a biomaterial-based wrap is not a viable 
treatment idea. This study highlights the possibilities for future work with biomaterial-based 
central nervous system injury treatments. 
Through this study many different analytical techniques were used. Skills is experimental 
planning, biomaterial synthesis, cell culture, handling animals, surgical and dissection procedures, 
tissue preparation and analysis, immunohistochemistry, image analysis, and statistical analysis 
were gained. This study took a lot of planning and coordination between multiple parties which 
was excellent preparation for a full-time career in any engineering field. This type of animal study 
was new to the Leipzig group. It was incredibly beneficial to work with NEOMED to leverage 
their expertise; however nothing beats personal experience. My advice to future students taking on 
this complex of a study in the future is to not be discouraged by failure, but to push on and learn 
from the mistakes made so the next round can be more successful.  
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Introduction 
 
According to the McKnight Brain Institute at the University of Florida, at least 10,000 
people per year in the United States alone suffer from a central nervous system (CNS) injury. 
These types of injuries in the worst cases can cause serve disabilities including paralysis. Due to 
the complexity of the spinal cord, it is common that potential CNS treatments are first applied to 
an optic nerve model. The purpose is of this project is to test the effects of nerve growth factor 
(NGF) sustained delivery to retinal ganglion cells (RGCs) after an optic nerve crush (ONC) was 
performed in vivo. A chitosan tube was prepared, and then biotinylated NGF (bNGF) was 
immobilized on the surface of the inside of the tube. For the ONC model, male Sprague Dawley 
rats were used. Through IACUC approved surgical procedures, the optic nerve of the right eye was 
exposed, a mild crush was administered using a micro-vascular clip, and then the chitosan tube 
was placed around the crush site and fibrin glue was used to hold the tube in place. The rats were 
observed over 21 days after the procedure. At day 18, a fluorescent marker was intravitreally 
injected. This marker traveled through the optic nerve and into the brain so the effectiveness of the 
treatment could be evaluated. In addition to immobilized NGF, crush sites were treated using 
fluorinated methacrylamide chitosan (MAC(Ali15)F), which is a fluorinated chitosan based 
material used to sequester and deliver oxygen from the environment to an injury site. This material 
has been investigated for wound healing application to provide additional oxygen to encourage 
healing. In this case, it was used to determine if it would also promote a good growing environment 
for the optic nerve crush. 
 
 Five different test groups were used in this experiment: No treatment (left eye), Crush, 
Chitosan Tube, immobilized NGF (ImmbNGF) and MAC(Ali15)F. The injuries and treatments 
were applied to the right eye of each rat. The left eye was used as a no treatment control group. 
The crush group had the injury applied, but no treatment. The chitosan group had the injury applied 
and will be treated with a chitosan tube without immobilized NFG. The ImmbNGF group had the 
injury applied and the chitosan with immobilized NFG applied to the crush site. The MAC(Ali15)F 
group had the injury applied and the MAC(Ali15)F tube applied. 
 
Background 
 
Retinal ganglion cells (RGCs) are a type of neuron associated with the retina of the eye 
that contains photoreceptors used to pass visual information to the brain. All types of RGCs have 
a long axon that extends from the retina to the brain, which in total make up the optic nerve (Lemke 
et. al., 2005; Oster et. al., 2004). RGCs can be damaged by compression of the optic nerve, which 
can be caused by glaucoma, malignancy, infection, and inflammation. This can cause retraction of 
axons, which will reduce the number of connections to the brain, leading to permanent damage to 
the ocular system (Chang et. al. 2012; Weber et. al., 2000). Loss of vision due to the lack of 
regeneration of the axon after injury is attributed to increases in reactive oxygen species, down 
regulation of neurotrophins, axonal transport failure and loss of electrical activity (Chang et. al. 
2012). RGC death, and permanent vision loss may be prevented be targeting RGC axon growth 
and regeneration soon after injury, before RGCs are fully compromised (Berkelaar et. al., 1994; 
Chrish et. al., 2010). Traditional treatments involve intravitreal injections of pharmacological 
agents, which are mainly used as protective measures and do not directly address axon retraction 
(Chang et. al., 2012; Hoyng et. al., 2000). Soluble guidance molecules, such as NGF, have been 
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shown to promote axon growth in vitro, and to slow axonal degeneration in the early stages of 
glaucoma (Chang et. al., 2012; Lambiase et. al., 2009; Shi et. al., 2007; Zhang et. al., 2011). When 
these trophic factors are delivered in a soluble from, their effects are often short lived, thus there 
is a need for a sustained release of these factors. This could be done using a biomaterial with an 
immobilized trophic factor. MAC(Ali15)F has been previously studied in wound healing 
applications in the Leipzig Lab because of the fluorine groups ability to sequester oxygen from the 
environment and deliver it to a would site.  It is thought that if additional oxygen is delivered to 
the crush site it will provide additional energy to spare axons; furthermore, MACF may provide 
the added benefit of reducing the damage inflicted by reactive oxygen species (Patil et. al., 2017). 
In addition, chitosan based materials like MAC(Ali15)F have been shown to have hemostatic and 
antibacterial properties as well (Pusateri et. al., 2003). These factors combined could potentially 
improve the healing environment around the crush site.  
 
Understanding RGC injuries and axon regeneration can aid in the development of a 
biomaterial-based strategy that can be used as a base for the treatment of other CNS injuries and 
diseases. For this reason, the optic nerve crush model was chosen to investigate the effectiveness 
of a biomaterial treatment for CNS injuries.   
 
Experimental Methods 
 
Treatment Material Development 
 
bNGF was be expressed, isolated and purified according to McCormick et. al. (2014). The 
chitosan tubes were made by dissolving chitosan in 2 V/V% acetic acid. The chitosan solution and 
100% ethanol in a 1:1 ratio were stirred from 30 minutes. Then acetic anhydride was added, then 
after stirring for 10 seconds, the solution was drawn up into a syringe and injected into the tube 
mold (Figure 1). The mold was set up right and the chitosan solution was left to dry for 24 hours. 
Then the tube was washed using deionized water for an additional 24 hours. The tube was then be 
boiled for 4 hours in 40wt% NaOH so that deacetylation will occur. Then the tube was washed 
with deionized water for another 24 hours. Then the tube was cut into 2 mm pieces and sterilized 
with 70% ethanol for 30 minutes. The tubes were placed upright and the bNGF was immobilized 
to the inner surface according to the procedures in McCormick et. al (2013). A protein release 
study was performed in 0.1M PBS and evaluated using a bNGF rat ELISA kit over 21 days.  
 
The MAC(Ali15)F was prepared according to Wijekoon et. al. 2012. The MAC(Ali15)F 
was formed into tubes in the same manner as the chitosan tubes.  
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Figure 1: Figure 1 summarizes the treatment material development, the optic nerve crush injury 
and treatment method, and the RGC labeling technique used for this experiment. 1. Shows the 
mold used to create the chitosan/MAC(Ali15)F tubes. 2. shows the completed tube. 3. Shows the 
immobilization of NGF on the chitosan tube for the ImmbNGF group. The optic nerve crush model 
is shown as the final stage of the experiment. The model was implemented by inflicting the crush 
injury using a micro-vascular clip, then applying the designated treatment to the injured area,, then 
the axons in the RGCs were labeled using cholera toxin B (CTB) conjugated with a fluorescent 
tag so the extent axonal injury and regeneration could be observed.  (McCormick, 2014). 
 
Behavioral Analysis 
 
 After the surgeries, the rats were evaluated using cage drop testing. This test was developed 
with help from Dr. Denise Inman at the Northeast Ohio Medical University. The theory is that if a 
rat is suspended above a cage lid by the tail, when it is able to see the surface, it will instinctively 
reach toward it. The height at which the rat recognizes the surface should correlate to its visual 
acuity. With the nonsurgical eye covered, the rat was raised by its tail 15cm above the cage lid, 
then lowered slowly toward the cage. A ruler in the background was used to determine the height 
at which the rat reaches toward the cage. A camera was used to record each trial. An observer that 
was blind to the study will record the distance at which the rat reaches for the cage. Each rat will 
get 5 trials and testing will occur on days 0, 1,7, 14, and 21, where day 0 is before the procedure.  
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Optic Nerve Crush Surgical Procedures 
 
 All of the surgical procedures used were approved by the Northeast Ohio Medical 
University IACUC and were performed aseptically. All personal wore sterile gloves and masks 
and instruments were sterilized and cleaned using 70% ethanol before surgeries. In between 
surgeries, a glass bead sterilizer was used to clean the instruments. Rats were anesthetized with 
isoflurane and were given a subcutaneous injection of ketoprofen before surgery for pain. 
Anesthetic was applied to the cornea. Using an operating microscope and small iridectomy 
scissors, a lateral canthotomy was performed, followed by a dissection of the conjunctiva of the 
right eye. The globe was rotated nasally using 9-0 conjunctival suture and tweezers to expose the 
optic nerve. The optic nerve was then subjected to a mild crush injury 2 mm from the globe using 
a micro-vascular clip that was held for 10 seconds. The 2mm chitosan tube treatments were cut 
into thirds, such that the wrap was 2mmx4mm. The tubes were placed on one side of the optic 
nerve and then cuffed at the top and bottom to wrap around the nerve. A biocompatible fibrin 
sealant was used to hold the tube in place. The eye was rotated back into place and the conjunctiva 
was laid back into place. One stitch of 10-0 absorbable suture was used to close the canthotomy.  
 
RGC Labeling 
 
 On day 18, cholera toxin B (CTB) conjugated with AlexaFluor 488 was intravitreally 
injected. The tracer labeled the RGCs. The rats were anesthetized with isoflurane, and 
proparacaine hydrochloride was applied to the cornea. A 33G hyprodermic needle was used to 
inject 3µL of the marker into the eye. 
 
Tissue Isolation and Immunohistochemistry Analysis 
 
 On day 21, an intra-cardiac perfusion with formaldehyde fixation was performed after an 
overdose of sodium pentobarbital. After the perfusion, the eyes, optic nerves and brain were 
isolated and stored in 0.1 PBS with sodium azide. The optic nerves will be isolated from the eyes 
and sectioned longwise on a sliding microtome with a cooling stage. The sections were mounted 
and imaged with a fluorescent microscope. To quantify the images, the intensity of the CTB marker 
was measured before and after the crush site and the ratio will be used to quantitatively compare 
the different treatment groups.  
 
Statistical Analysis 
 
 A two factor analysis of variance (ANOVA) was performed with Minitab software for the 
behavioral analysis and the CTB marker intensity ratio data. These data are reported as mean ± 
standard deviation (SD). Significance was established with an α level of 0.05.  
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Figure 2: The figure above shows demonstrates the surgical procedure used for the optic nerve 
crush. (A) After the canthotomy, sutures through the conjunctive were used to rotate the globe 
nasally. (B) Forceps were used to expose the optic nerve. (C) The chitosan or MAC(Ali15)F tube 
treatments were places around the optic nerve. (D) After placing the fibrin glue sealant and rotating 
the globe back into place, a single suture was used to close the canthotomy. Note that these pictures 
were from practice surgeries with cadaver rats, and that the eyes have been moved to further expose 
the optic nerve for demonstration purposes. In the actual surgeries, the optic nerve was not exposed 
as grossly and the treatments did not wrap all of the way around the optic nerve. (McCormick, 
2014). 
 
 
Results and Discussion 
 
bNGF Protein Release from Chitosan Tubes 
 
The release of bNGD in vitro was evaluated over 21 days in 0.1M PBS. Samples were 
extracted from chitosan tube samples containing ImmbNGF. The total bound protein would be 
38ng, given that 100 L of 1,000 ng/mL solution was added to each tube and bNGF has a 38% 
binding efficiency (McCormick et. al., 2013). The total release of bNGF from the ImmbNGF 
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chitosan tubes at day 21 was 630±160 pg. This is less then 2% of the total protein in the tube, so 
the majority was not released in to the PBS, shown in Figure 3. This indicates that the majority of 
the protein remains attached to the chitosan substrate. This was suspected, considering that the 
bNGF is covalently bonded with the chitosan.  
 
 In a study completed by Mey and Thanos, 1992, a dosage of 50 ng of different growth 
factors was injected intravitreally to promote RGC survival after the transection of the optic nerve. 
The dosage delivered by the ImmbNGF chitosan tube was significantly lower than this study, 
however the amount of protein present at the injection site at the end of the experiment was not 
quantified so a direct comparison cannot be made. The downside of the injection method is that 
the effects were short term, thus multiple injections were required to see long term RGC survival. 
The need for a sustained delivery directly to the injury site is still needed. In addition to 
immobilized protein applications, soluble protein treatments should be considered to maximize 
protein delivery to the injury site.  
 
 
 
Figure 3: The figure above was adapted from a previous work about the same study 
(McCormick, 2014). The cumulative bNGF release from ImmbNGF (listed as ImNGF in the 
figure) chitosan tubes was measured over 21 days, shown by the solid line. Very little protein 
was released compared to the total amount of protein immobilized on the chitosan, shown by the 
dotted line. The MixNGF and Mix+ImNGF included soluble NGF in the material, however it 
was later discovered that an error in the material preparation would have degraded all of the 
soluble protein, which is why those two groups were not considered for this work. The mean ± 
standard deviation of the cumulative bNGF release is plotted, n=6.  
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Behavioral Analysis 
 
 The visual depth perception of the rats was evaluated using the cage drop method described 
in the Materials and Methods , where the distance at which rats were able to recognize the top of 
a cage when lowered towards was measured. This was performed was measured before and after 
the ONC procedures on days 0 (before procedure), 1, 7, 14, and 21. The results of the cage drop 
testing are shown in Figure 4A. For this type of behavioral analysis, it is critical to establish a base 
line prior to the start of the experiment so any changes after the experiment can be properly 
evaluated. The was only a significant difference between the Chitosan Tube group on days 0 and 
, indicating that a true base line was not established because there is not a significant difference 
between day 0 and day 1 for all groups. Many other factors could have affected the results of this 
test. Inflammation, infection, and irritation of the surgical area could have influenced the results 
in addition to the injury itself. In addition, the amount of handling and the individual performance 
of the rats could have affects the results. Figure 4B-E shows the trends for the individual rats in 
the study. In general, there is a decrease from day 0 to day 1, and a general increase from day 1 
forward, but it is not consistent for each rat. For example, three rats in the Chitosan Tube group 
showed a significant change between day 0 and day 1 and a steady increase in performance up to 
day 14. These three rats in particular were part of the preliminary study and experienced greater 
handling than the other rats in the study, which may explain why their results are more pronounced. 
To truly determine the impact of the injury and the different treatments, the further analysis of the 
tube placements, crush severity, and RGC health is required. In the future, other types of more 
established methods of assessing visual acuity, such as cliff test and the water box test, should be 
considered (Fox, 1965; Prusky et. al., 2000).  
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Figure 4: The figure above shows the cage drop test results that were used to access the visual 
acuity of the rats before and after the ONC. (A) The mean height ± standard deviation for the cage 
were the rats reached out is shown for each treatment group on days 0, 1, 7, 14, and 21m where 
day 0 is before the ONC procedure. The error bars show the standard deviation. The * indicates a 
statistically significant difference between those groups determined by two-factor ANOVA. (B-E) 
The performance of individual rats was plotted for each group to show the differences in how each 
rat responded to the test. Each line represents an individual rat. The sample size for all groups was 
n=6 except for MAC(Ali15)F, which was n=5.   
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ONC Model Execution and Tissue Isolation 
 
 After day 21, the eyes and optic nerves both the right and left eyes of each rat were isolated. 
During the tissue isolation, the placement of the chitosan and MAC(Ali15)F tubes was evaluated. 
Correct tube placement was only observed 50% of the time, show in Figure 5A. It is believed that 
when the eye was rotated back into position that the tube would shift out of place, causing it to lie 
on the back of the globe, as shown in Figure 5B. This indicates that a change in the tube design is 
required. It is possible that a tube with a smaller diameter would stay in place better. In addition 
to the tube placement, the actual crush site was evaluated. Only 28% of the rats had a crush site 
that was visible through the dissection microscope. From the fluorescent microscopy performed 
on the sectioned optic nerves (discussed further later), only 39% of the rats showed evidence of a 
crush injury. This indicated that the surgical tools and procedures needs improvement in order to 
have a consistent injury every time. Traditionally, tweezers are used to inflict the crush injury 
(Tang et. al., 2011; Templeton et. al., 2012), but consistent pressure for each injury was a concern. 
It was thought that using a micro-vascular clip would standardize the amount of pressure applied 
for each crush injury, however, due to the other tissue around the optic nerve, it was difficult to 
place the clip during the procedure. This could be improved with more practice, or the employment 
of a surgeon. In addition, other injury models such as the optic nerve stretch model where the optic 
nerve is mechanically stretched to induce an injury. This type of injury can be less severe than a 
crush or transection injury, thus allowing one to investigate a mild injury, which is more common 
in humans (Maxwell et. al., 1994).  
 
 
 
Figure 5: The images above show eyes and optic nerves used to analyze the treatment tube 
placement. (A) The tube placement was in the correct location on the ONC site. (B) The tube was 
shifted after placement and stuck to the back of the globe of the eye. (C) After dissection, the optic 
nerves were separated from the eye and cleaned. ONC sites could be identified by the discoloring 
on the never approximately 2 mm away from the eye. The arrows designate either the tube (A-B) 
or the crush site (C). (McCormick, 2014). 
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CTB Intensity Analysis 
 
 On day 18 of the study, both the right and left eyes were injected with CTB to label the 
axon tracks in the optic nerve. After isolation, optic nerves were sectioned, mounted, and imaged 
using a fluorescent microscope. Figure 6A-B shows a comparison of the right and left optic nerves. 
The crush site is evident in Figure 6B not only by the narrowing of the optic nerve, but the bright 
spotting of CTB, which was evident in most of the confirmed crush sites. In addition to the CTB, 
GFAP was used to study the astrocyte expression in the optic nerve. As shown in Figure 6C-D, 
the uninjured left optic nerve shows very little astrocyte expression, where there is high expression 
on the injured optic nerve, especial around the crush site. This verifies that astrogliosis is occurring, 
where reactive astrocytes increase, confirming that an injury occurred.  
 
Using ImageJ software, the intensity of the CTB staining in a region of interest, like the 
ones shown in Figure 6A-B, was quantified before and after the crush. The ratio of the post-crush 
and pre-crush CTB intensity were used to compare each treatment group to the left, uninjured, 
optic nerves. The results are show in Figure 7.  Using two way ANOVA, it was shown that there 
was a statically significant difference between the intensity ratio of the right and left optic nerves. 
This indicates that an injury was inflicted to the right optic nerves and it was detectable by the 
CTB intensity. However, there was no statistical significant difference between the different 
treatment groups and the crush with no treatment.  
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Figure 6: The images above show the longitudinal sections of injured and non-injured (sham) 
optic nerves with CTB labeling and astrocyte activation and distribution. (A-B) An example of a 
region of interest is shown after the crush site. This region of interest was used to measure the 
intensity of the CTB labeling. The microscope image settings and expose were kept constant to 
ensure the intensities were comparable. (C-D) Astrocyte expression was evaluated using a GFAP 
label. (C) shows minimal expression where (D) shows much higher astrocyte expression, 
especially around the crush site indicating that there was a response to the injury. Like (A-B), (C-
D) were imaged using the same microscope parameters so the intensity could be compared. Scale 
bar = 100 m. (McCormick, 2014). The arrows on (B) and (D) indicate the crush sites. 
 
 
17 
 
 
Figure 7: The mean ± standard deviation of the ratio of CTB intensity before and after the crush 
site was determine for both the right and left optic nerves of the rats in each treatment group. The 
right optic nerves were subjected to the ONC, and the left serve as a control. The crush group 
received the injury, but no treatment. The * indicates a statistically significant difference by two 
way ANOVA. For all groups the sample size was n=6, apart from MAC(Ali15)F which was n=5.  
 
Conclusions 
 
 Two different treatment methods were employed to the ONC model through this study. 
One where NGF was immobilized to a chitosan substrate in an attempt to stimulate axonal 
regeneration, and the other made from MAC(Ali15)F was used in an attempt to promote a healing 
environment. From the ratio of CTB intensity results, it is clear that an injury was created, however, 
there was no difference between the treatments and the untreated injured optic nerve. Since the 
crush injuries were difficult to identify visually, it indicates that the injury itself may not have been 
severe enough to detect a difference between the treatments. Using a more severe injury model 
could have improved the efficacy of the treatment by making the difference between the treatments 
more discernable. In addition, the rat model may not have been the most appropriate choice since 
the rat optic nerve does not have the central retinal artery, like a human’s does. A rabbit model 
may be more appropriate since its optic nerve anatomy is more similar to the human’s (Gwon, 
2008).  The surgical model can also be improved by either adjusting the tools and techniques used 
for the optic nerve crush, or by selecting a model that is easier to control, such as the optic nerve 
stretch model (Maxwell et. al., 1994). In addition, the treatments could be improved by integrating 
a soluble protein to increase the dosage to the injury site, or by incorporating more than other 
neural guidance molecules in addition to NGF (Mey et. Al., 1992). Previous works have shown 
NGF’s ability to guide axonal growth, however MAC(Ali15)F has not. In order to determine the 
efficacy of MAC(Ali15)F used for neural regeneration, in vitro experiments should be performed 
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so that all external variables are controlled and the impact of MAC(Ali15)F alone can be assessed. 
Since MAC(Ali15)F was formulated for external wound treatments, other additional preparations, 
such as oxygen recharging, may be required for it to aid in the treatment of an internal injury. 
Other delivery methods like the injection of the hydrogel should also be considered. This may 
better ensure the correct placement of the treatment and would be less invasive when applied to a 
pre-existing injury. This work has highlighted key areas that need further understanding and 
investigation in order to develop an effective biomaterial treatment of central nervous system 
injuries, especially optic nerve sparing or regeneration.  
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